FDAnews Device Daily Bulletin

NEW NANOTECHNOLOGY RECEIVES FDA APPROVAL -- SETTING STAGE FOR NEW ERA IN BATTLE AGAINST HOSPITAL RELATED INFECTIONS

Dec. 13, 2005
A A

AcryMed Inc. today announced clearance from the Food And Drug Administration (FDA) for the first use of SilvaGard, the company's breakthrough silver nanotechnology that can render existing medical devices impervious to infection-causing bacteria. Unlike any other infection control technology available today, SilvaGard can be used to treat virtually any medical device and its use does not alter the device's original properties. Due to these and other unique attributes, SilvaGard is expected to have a significant impact on the battle against hospital-related infections.

Nanotechwire (http://nanotechwire.com/news.asp?nid=2671)